Page 405 - Multidisipliner Covid 19
P. 405

COVID-19 Dermatolojik Bulgular›


                      May 6, 2020. doi:10.1001/jama.2020.8259’
                   63. Torres-Navarro I, Abril-Pérez C, Roca-Ginés J, Sánchez-Arráez J, Botella-
                      Estrada R. A case of cefditoren-induced Acute Generalized Exanthema-
                      tous Pustulosis during COVID-19 pandemics. Severe Cutaneous Ad-
                      verse Reactions (SCARs) are an issue. J Eur Acad Dermatol Venereol.
                      2020 May 26. doi: 10.1111/jdv.16664. [Epub ahead of print]. Case report.
                      https://doi.org/10.1111/jdv.16664
                   64. Sakaida T, Isao T, Matsubara A, Nakamura M, Morita A. Unique skin
                      manifestations of COVID-19: Is drug eruption specific to COVID-19?
                      J Dermatol Sci. 2020 May 16. doi: 10.1016/j. jdermsci. 2020.05.002.
                      [Epub ahead of print]. Case report.
                      https://doi.org/10.1016/j. jdermsci. 2020.05.002
                   65. Skroza N, Bernardini N, Balduzzi V, Mambrin A, Marchesiello A,
                      Michelini S, Tolino E, Proietti I, Di Cristofano C, Petrozza V, Potenza
                      C. A late onset widespread skin rash in a previous Covid-19 infected
                      patient: viral or multidrug effect? J Eur Acad Dermatol Venereol. 2020
                      May 18. doi: 10.1111/jdv.16633. [Epub ahead of print]. Case report.
                      https://doi.org/10.1111/jdv.16633
                   66. Litaiem N, Hajlaoui K, Karray M, Slouma M, Zeglaoui F. Acute general-
                      ized exanthematous pustulosis after COVID-19 treatment with hydroxy-
                      chloroquine. Dermatol Ther. 2020 May 13: e13565. doi: 10.1111/dth.13565.
                      [Epub ahead of print] No abstract available. Case report.
                      https://doi.org/10.1111/dth.13565
                   67. Sernicola A, Carnicelli G, Di Fraia M, Chello C, Furlan C, Muharremi
                      R, Paolino G, Grieco T. "Toxic erythema" and eosinophilia associated
                      to tocilizumab therapy in a COVID-19 patient. J Eur Acad Dermatol
                      Venereol. 2020 May 9. doi: 10.1111/jdv.16620. [Epub ahead of print].
                      Case report. https://doi.org/10.1111/jdv.16620
                   68. Robustelli Test E, Vezzoli P, Carugno A, Raponi F, Gianatti A, Rongioletti
                      F, Sena P. Case report. Acute generalized exanthematous pustulosis
                      with erythema multiforme-like lesions in a COVID-19 woman. J Eur
                      Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16613. [Epub
                      ahead of print].https://doi.org/10.1111/jdv.16613
                   69. Mauro Grandolfo, Paolo Romita, Domenico Bonamonte, Gerardo
                      Cazzato, Katharina Hansel, Luca Stingeni, Claudio Conforti, Roberta
                      Giuffrida, Caterina Foti. Drug reaction with eosinophilia and systemic
                      symptoms syndrome to hydroxychloroquine, an old drug in the




                       404
   400   401   402   403   404   405   406   407   408   409   410